Mirvie Nature Communications Publication

Now available to predict preeclampsia risk

Encompass™ provides objective data for implementing an evidence-based action plan early enough to reduce your risk.

Reduce preterm birth

Predicts preeclampsia risk early enough to implement preventive action and extend gestational age.

Reduce NICU days

Early risk identification and adherence to evidence-based action plans saves an average of 2 NICU days for every 3 high-risk patients tested.

Reduce overall costs

Focuses clinical resources on elevated risk pregnancies to reduce costly complications through targeted care for those who need it.

Reduce deliveries in crisis

Replaces reactive emergent care with proactive, biomarker-guided management for the healthiest pregnancy possible.

A breakthrough shaping the future of pregnancy health.

The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test.^1,2,3

The platform reveals vital information about a pregnancy's unique biology by analyzing tens of thousands of RNA messages that drive dramatic changes throughout pregnancy.^1,2,3

The power to transform how we predict, prevent, and treat unexpected complications.

RNA molecules sequenced from a single blood sample could predict preeclampsia months before symptoms appear.

The researchers found the model could identify three-quarters of women who would later develop preeclampsia early in their pregnancies.

“It’s often in the first trimester that a lot of the onset of the condition happens biologically,” despite symptoms appearing late in pregnancy.

Detecting preeclampsia after symptoms arise “leaves you very little time to address the challenge. And it’s mostly crisis management.”

A Personalized Window Into Pregnancy

The underlying biology of pregnancy health revealed.

For the first time in history, the Mirvie RNA platform reveals a fundamental understanding of the underlying biology of each unique pregnancy, including pregnancy complications.^1,2,3

This breakthrough can enable proactive, preventive, and personalized pregnancy care for the well-being of millions of moms and babies.

The Mirvie RNA Platform

The platform combines revolutionary analysis of tens of thousands of RNA messages from the baby, the placenta and the mom, with machine learning.^1,2,3

Using a simple blood test, it reveals RNA messages driving the dramatic changes in pregnancy, like a baby’s growth and a mom’s body.^1,2,3

The platform can predict complications months earlier based on the underlying biology of each unique pregnancy. ^1,2,3

This creates a new window for moms to act and their doctors to intervene before a complication becomes a crisis.^1,2,3

Landmark Pregnancy Health Research

Paradigm-shifting study shows simple blood test can identify 91% of pregnancies that will develop preterm preeclampsia months before symptoms.

Current guidelines and approaches to assessing preeclampsia risk are failing the majority of pregnant moms, resulting in ineffective preventive care.

Study shows the Mirvie RNA Platform predicts 76% of early preterm birth cases and identifies distinct pathways driving the condition’s development.

Latest Research

Pregnancy care can now be personalized, predictive and proactive